Filter
5285
Text search:
drug
access
Featured
Recommendations
472
New Publications
1401
Language
Document type
No document type
3144
Studies & Reports
888
Guidelines
633
Manuals
236
Strategic & Response Plan
177
Fact sheets
75
Training Material
68
Situation Updates
23
Infographics
16
Resource Platforms
12
Brochures
6
Online Courses
3
App
2
Videos
1
Countries / Regions
India
285
Global
188
Kenya
166
South Africa
140
Uganda
128
Ethiopia
120
Nigeria
115
Western and Central Europe
113
Tanzania
101
Nepal
90
Sierra Leone
87
Liberia
85
Malawi
85
Africa
85
Zambia
82
Myanmar / Burma
78
Latin America and the Carribbean
74
Bangladesh
69
Ghana
67
Rwanda
67
Eastern Europe
59
Namibia
56
Ukraine
55
Asia
44
Zimbabwe
43
Philippines
43
Cambodia
36
Lesotho
36
South–East Asia Region
36
Russia
27
Congo, Democratic Republic of
26
Botswana
26
Syria
24
Senegal
23
Indonesia
23
Mozambique
23
Burkina Faso
21
Eswatini/ Swaziland
19
East and Southern Africa
19
Cameroon
16
South Sudan
16
Brazil
16
Haiti
15
Colombia
15
West and Central Africa
15
Thailand
13
Eastern Europe and Central Asia
12
USA
11
Middle East and North Africa
11
Venezuela
11
Albania
11
Tajikistan
11
Guinea
10
Pakistan
10
China
10
Georgia
10
Vietnam
10
Afghanistan
9
Germany
9
Benin
9
Moldova
8
Sudan
7
Laos
7
North Macedonia
6
Mexico
6
Sri Lanka
6
Western Pacific Region
6
Armenia
6
North America
6
Mali
5
Iraq
5
Jordan
5
Lebanon
5
Central African Republic
5
Peru
5
Somalia
4
Turkey
4
Argentina
4
El Salvador
4
Libya
4
Yemen
4
Timor Leste/ East Timor
4
Iran
4
Jamaica
4
United Kingdom
4
Côte d’Ivoire / Ivory Coast
3
Papua New Guinea
3
Honduras
3
Bolivia
3
Madagascar
3
Bhutan
3
Palestine
3
Kyrgyzstan
3
Morocco
2
Saudi Arabia
2
Chad
2
Switzerland
2
Serbia
2
Hungary
2
Guatemala
2
Nicaragua
2
Chile
2
Poland
2
Southern Africa
2
Canada
2
Uzbekistan
2
Kazakhstan
2
Gabon
2
France
2
Portugal
2
Spain
2
Belarus
2
Niger
1
Egypt
1
Gambia
1
Ireland
1
Singapore
1
Dominican Republic
1
Ecuador
1
Greece
1
Paraguay
1
Fiji
1
North Korea
1
Italy
1
Mongolia
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Estonia
1
Romania
1
Lithuania
1
Australia
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Norway
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
2023
Clinical Guidelines
429
Public Health
247
Women & Child Health
205
Key Resources
157
Capacity Building
84
Pharmacy & Technologies
55
Annual Report MEDBOX
1
Toolboxes
HIV
705
Mental Health
486
TB
484
AMR
257
NTDs
202
COVID-19
196
Pharmacy
151
NCDs
106
Malaria
101
Caregiver
100
Ebola & Marburg
78
Planetary Health
69
Refugee
67
Disability
62
Conflict
62
Rapid Response
60
Global Health Education
59
Health Financing Toolbox
51
2.0 Rapid Response
25
Cholera
22
Polio
19
Natural Hazards
18
Zika
16
Specific Hazards
14
Social Ethics
13
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the chan
...
Mpox Molecular Diagnostic Tests(RT-PCR)
recommended
March 2025. Access to appropriate, quality-assured diagnostics remains a challenge. There is limited information on key characteristics of available test kits, including their performance, reliability, and ability to detect relevant Mpox clades. Add
...
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul
...
This study aimed to determine the drug resistance profile of Mycobacterium tuberculosis in Mozambique and concludes that M. tuberculosis resistance to antituberculosis drugs is high in Mozambique, especially in previously treated patients. The frequ
...
The use of Delamanid and Bedaquiline for Children with Drug-Resistant Tuberculosis.
This report reviews and analyses the Affordable Medicines Programme, which was introduced in Ukraine in April 2017 to provide patients with improved access to 23 outpatient medicines for the treatment of chronic noncommunicable diseases. The evaluat
...
World malaria report 2025
recommended
Addressing the threat of antimalarial drug resistance. This year’s report spotlights the growing threat of antimalarial drug resistance. Partial resistance to artemisinin derivatives – the backb
...
WHO operational handbook on tuberculosis: module 4: treatment: tuberculosis care and support
recommended
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis,
...
The COVID-19 pandemic has impacted regular cardiovascular healthcare access and delivery. Service utilisation has declined, and excess cardiovascular mortality has been reported in several countries. We aim to estimate excess cardiovascular deaths i
...
Submitted to the US Agency for International Development by the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program. Arlington, VA: Management Sciences for Health. Submitted to the United Nations Children’s Fund by JSI, Arl
...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to report adverse reactions to medicines. The purpose is to help countries set up a well-organized and effective consumer reporting system within their pharmac
...
These guidelines provide a framework for effective action to facilitate access to safe and ethical
testing services for different population groups. The implementation of the a comprehensive
approach, known as HIV Testing Services (HTS) is cardina
...
The NDMS&IP focuses on mainstreaming disability to promote equitable access to services in the six thematic areas of health, education, livelihoods, empowerment, and social inclusion and cross-cutting issues.
The first part of the NDMS&IP outlines
...
BMC Infectious Diseases (2019) 19:832
Intestinal schistosomiasis is highly endemic in Tanzania and mass drug administration (MDA) using
praziquantel is the mainstay of the control program. However, the MDA program covers only school aged children
...
This report aims to estimate the economic cost of providing regular access to healthcare for migrants in an irregular situation, compared with the cost of providing treatment in emergency cases only. Two specific medical conditions – hypertension
...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associa
...
Tuberculosis treatment failure results in increased risk of morbidity, drug resistance, transmission and mortality. There are few data about tuberculosis treatment outcomes in Burkina Faso. The current study investigated the factors associated with
...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resis
...